5.05
price up icon1.00%   0.05
 
loading
前日終値:
$5.00
開ける:
$5.05
24時間の取引高:
722.60K
Relative Volume:
1.05
時価総額:
$410.96M
収益:
$70.14M
当期純損益:
$-76.24M
株価収益率:
-4.5495
EPS:
-1.11
ネットキャッシュフロー:
$-57.06M
1週間 パフォーマンス:
+11.48%
1か月 パフォーマンス:
-4.36%
6か月 パフォーマンス:
+42.25%
1年 パフォーマンス:
+87.73%
1日の値動き範囲:
Value
$5.015
$5.43
1週間の範囲:
Value
$4.63
$5.43
52週間の値動き範囲:
Value
$2.53
$6.08

Codexis Inc Stock (CDXS) Company Profile

Name
名前
Codexis Inc
Name
セクター
Healthcare (1176)
Name
電話
650-421-8100
Name
住所
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Name
職員
174
Name
Twitter
@codexisinc
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
CDXS's Discussions on Twitter

CDXS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CDXS
Codexis Inc
5.05 410.96M 70.14M -76.24M -57.06M -1.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Codexis Inc Stock (CDXS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-19 ダウングレード The Benchmark Company Buy → Hold
2024-06-03 再開されました Jefferies Buy
2024-05-30 開始されました Cantor Fitzgerald Overweight
2024-02-29 アップグレード The Benchmark Company Hold → Buy
2023-11-07 ダウングレード The Benchmark Company Buy → Hold
2023-08-07 ダウングレード TD Cowen Outperform → Market Perform
2023-05-09 ダウングレード H.C. Wainwright Buy → Neutral
2022-03-31 再開されました Piper Sandler Overweight
2022-03-02 再開されました Cowen Outperform
2021-04-12 開始されました Piper Sandler Overweight
2021-03-01 開始されました Stifel Buy
2021-02-26 繰り返されました H.C. Wainwright Buy
2020-03-10 開始されました The Benchmark Company Buy
2019-01-17 アップグレード First Analysis Sec Neutral → Outperform
2018-05-16 開始されました Stephens Overweight
2017-10-13 繰り返されました H.C. Wainwright Buy
2017-05-31 開始されました Jefferies Buy
2017-01-26 ダウングレード First Analysis Sec Overweight → Equal-Weight
2017-01-04 アップグレード Ladenburg Thalmann Neutral → Buy
2016-01-06 開始されました H.C. Wainwright Buy
すべてを表示

Codexis Inc (CDXS) 最新ニュース

pulisher
Jan 20, 2025

Codexis expands board with new director Christos Richards - MSN

Jan 20, 2025
pulisher
Jan 19, 2025

Codexis, Inc. (NASDAQ:CDXS) Sees Significant Increase in Short Interest - MarketBeat

Jan 19, 2025
pulisher
Jan 17, 2025

Codexis expands board with new director Christos Richards By Investing.com - Investing.com Australia

Jan 17, 2025
pulisher
Jan 17, 2025

Tallon Kerry Patrick Purchases New Position in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Barclays PLC Purchases 70,255 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jan 17, 2025
pulisher
Jan 17, 2025

Barclays PLC Has $640,000 Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Jan 17, 2025
pulisher
Jan 16, 2025

Codexis appoints new independent director By Investing.com - Investing.com Australia

Jan 16, 2025
pulisher
Jan 16, 2025

Codexis, Inc. Appoints Christos Richards to Board of Directors -January 16, 2025 at 04:05 pm EST - Marketscreener.com

Jan 16, 2025
pulisher
Jan 16, 2025

Codexis appoints new independent director - Investing.com India

Jan 16, 2025
pulisher
Jan 16, 2025

Codexis Appoints Christos Richards to Board of Directors - TipRanks

Jan 16, 2025
pulisher
Jan 16, 2025

Codexis Strengthens Board with Life Sciences Veteran Christos Richards, Expert in 450+ Executive Placements - StockTitan

Jan 16, 2025
pulisher
Jan 14, 2025

Jane Street Group LLC Reduces Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jan 14, 2025
pulisher
Jan 14, 2025

Codexis (NASDAQ:CDXS) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Codexis (NASDAQ:CDXS) Stock Crosses Above Two Hundred Day Moving Average – What’s Next? - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

Synthetic DNA Market Set to Witness Stunning Growth by 2024 Ti - openPR

Jan 13, 2025
pulisher
Jan 10, 2025

Codexis Announces New Employment Inducement Grants - GlobeNewswire

Jan 10, 2025
pulisher
Jan 10, 2025

Codexis Awards Strategic Equity Grants to New Employees Under 2024 Inducement Plan - StockTitan

Jan 10, 2025
pulisher
Jan 10, 2025

Is There An Opportunity With Codexis, Inc.'s (NASDAQ:CDXS) 22% Undervaluation? - Yahoo Finance

Jan 10, 2025
pulisher
Jan 08, 2025

Codexis sees $210,994 stock purchase by Opaleye management - Investing.com Nigeria

Jan 08, 2025
pulisher
Jan 05, 2025

Geode Capital Management LLC Boosts Stake in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jan 05, 2025
pulisher
Jan 02, 2025

Caribou Biosciences Strengthens Leadership Team with Veteran Biotech CFO Sri Ryali - StockTitan

Jan 02, 2025
pulisher
Jan 02, 2025

Codexis sees $210,994 stock purchase by Opaleye management By Investing.com - Investing.com South Africa

Jan 02, 2025
pulisher
Jan 01, 2025

Codexis, Inc. (NASDAQ:CDXS) Short Interest Up 10.5% in December - MarketBeat

Jan 01, 2025
pulisher
Dec 30, 2024

State Street Corp Acquires 41,480 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World

Dec 30, 2024
pulisher
Dec 27, 2024

Stifel Financial Corp Lowers Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Dec 27, 2024
pulisher
Dec 27, 2024

Stifel Financial Corp Has $530,000 Position in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Dec 27, 2024
pulisher
Dec 20, 2024

BNP Paribas Financial Markets Trims Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

Codexis (NASDAQ:CDXS) Stock Price Crosses Above 200-Day Moving AverageHere's Why - MarketBeat

Dec 19, 2024
pulisher
Dec 17, 2024

Codexis's SWOT analysis: enzymatic pioneer's stock poised for RNAi revolution - Investing.com India

Dec 17, 2024
pulisher
Dec 16, 2024

Codexis's SWOT analysis: enzymatic pioneer's stock poised for RNAi revolution By Investing.com - Investing.com South Africa

Dec 16, 2024
pulisher
Dec 14, 2024

Codexis, Inc.'s (NASDAQ:CDXS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last week - Yahoo Finance

Dec 14, 2024
pulisher
Dec 10, 2024

Is Codexis (NASDAQ:CDXS) Using Debt In A Risky Way? - Simply Wall St

Dec 10, 2024
pulisher
Dec 08, 2024

Jacobs Levy Equity Management Inc. Decreases Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Dec 08, 2024
pulisher
Dec 06, 2024

Codexis Awards Strategic Equity Package: 208K Shares in Options and RSUs for Key New Hires - StockTitan

Dec 06, 2024
pulisher
Dec 05, 2024

Codexis stock soars to 52-week high, touches $4.92 By Investing.com - Investing.com Canada

Dec 05, 2024
pulisher
Dec 04, 2024

Codexis stock soars to 52-week high, touches $4.92 - Investing.com India

Dec 04, 2024
pulisher
Dec 04, 2024

Global Artificial Sweeteners Market to Observe Growth at a CAGR of ~4% by 2030 | DelveInsight - GlobeNewswire Inc.

Dec 04, 2024
pulisher
Dec 02, 2024

Codexis, Inc. (NASDAQ:CDXS) Shares Sold by Fred Alger Management LLC - MarketBeat

Dec 02, 2024
pulisher
Dec 01, 2024

Codexis, Inc. (NASDAQ:CDXS) Sees Large Decrease in Short Interest - MarketBeat

Dec 01, 2024
pulisher
Nov 26, 2024

Cantor Fitzgerald Reaffirms “Overweight” Rating for Codexis (NASDAQ:CDXS) - Defense World

Nov 26, 2024
pulisher
Nov 26, 2024

Codexis's SWOT analysis: enzymatic platform poised to shake up RNAi stock - Investing.com

Nov 26, 2024
pulisher
Nov 23, 2024

Codexis (NASDAQ:CDXS) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat

Nov 23, 2024

Codexis Inc (CDXS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
大文字化:     |  ボリューム (24 時間):